Literature DB >> 19579639

Gastric phenotypic expression and histogenesis of metachronous gastric cancers endoscopically resected.

Tsutomu Mizoshita1, Hiromi Kataoka, Satoshi Tanida, Makoto Sasaki, Naotaka Ogasawara, Eiji Kubota, Tsuneya Wada, Tomonori Yamada, Yoshinori Mori, Takaya Shimura, Tetsuya Tsukamoto, Masae Tatematsu, Takashi Joh.   

Abstract

BACKGROUND/AIMS: Endoscopic Resection (ER) has been performed for early gastric cancers, and metachronous gastric cancers (MGCs) were occasionally observed. Most MGCs were classified histologically as the differentiated type. However, there have been no data on the gastric and intestinal phenotypic classification of MGCs. In our previous study, Hp-infection in MG may trigger intestinalization of gastric cancers. We therefore speculate the phenotype shift in MGC lesions under Hp-chronic-infection.
METHODOLOGY: We examined the 17 MGC lesions phenotypically and histologically by using several gastric and intestinal epithelial cell markers, MUC5AC, MUC6, MUC2 and villin.
RESULTS: Most lesions (16/17) exhibited the differentiated type. In 8 first cancers, the lesions were divided phenotypically into 2 G, 4 GI, 1 I, and 1 N types. In 9 second/third cancers, the lesions were divided phenotypically into 3 G, 1 GI, 4 I, and 1 N types. The first lesions (6/8) had more gastric phenotypic expression compared with the second/third ones (4/9) in the MGCs, although there was no significant difference between two groups (P = 0.28).
CONCLUSION: Our present data suggest the possibility that the cancer retaining G type is detected endoscopically earlier than that obtaining the intestinal phenotypic expression by the phenotypic shift, which may partially explain the MGC occurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579639

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

Review 1.  Successful management of rare gingival metastasis from gastric adenocarcinoma: a case report and literature review.

Authors:  Zhili Wu; Jun Tang; Yan Li; Husheng Lu; Jun Xu; Donglai Lv
Journal:  World J Surg Oncol       Date:  2017-08-01       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.